Roku will be the first major streamer to use measurement firm iSpot's Outcomes at Scale metric in a bid to improve targeting ...

Spot attribution powers Roku's optimization for better campaign performanceNEW YORK--(BUSINESS WIRE)--Roku, Inc. (NASDAQ: ...

In recent days, Roku has attracted renewed attention as multiple analysts upgraded or reaffirmed positive ratings and the company deepened advertising measurement partnerships with Nielsen and iSpot ...

When Paramount Global sells commercials in this year’s “upfront” ad market, the media won’t only be guaranteeing the size of viewership for different shows. It may be in a position to do deals based ...

Paramount Global is teaming up with iSpot.tv to offer more transparency into consumers’ responses to ads — its latest partnership with a Nielsen competitor. iSpot’s new measurement offering, Outcomes ...

What is the meaning of life? What happens after we die? Did my campaigns actually work? That last question is a tricky one. And only large brands typically have the budget for detailed post-campaign ...

AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April, according to data released by iSpot.tv on Wednesday afternoon. The psoriasis treatment garnered an impressions ...

iSpot, the cross-platform TV ad measurement company, has released the company’s Quick Serve Restaurant (QSR) Outcomes Ranker, offering a look at the top-performing QSR creatives, genres, and dayparts ...

Dupixent is back on top as the pharma brand that took home the most TV impressions in May, according to data released by iSpot.tv on Thursday morning. Regeneron and Sanofi’s eczema and asthma ...

Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...

Jools Lebron sat down with Ad Age after her fireside chat to pull back the curtain on how she’s evolving her approach to brand partnerships.

Though spending on pharmaceutical TV ads picked up last month following a summer slump, the third quarter’s overall total still paled in comparison to the preceding periods this year. In Q3, the top ...